Athos Therapeutics Inc
Priti Prasad, PhD, currently serves as the Director of Regulatory Affairs at Athos Therapeutics Inc, where responsibilities include planning and implementing regulatory strategies for novel oncology drugs and conducting Phase I and II clinical studies in the US and Australia. Previous roles include Senior Manager of Regulatory Strategy at ICON plc, focusing on oncology and diabetes products, and Senior Manager of Regulatory Affairs at Sirnaomics, where Priti contributed to clinical trial submissions. Other experience includes managerial positions at Prolacta Bioscience and Amgen, and regulatory roles at GlaxoSmithKline, Wrigley, and Pfizer. Priti holds a PhD in Molecular Toxicology from UCLA, an MS in Toxicology from Jamia Hamdard, and a BS in Zoology from Delhi University.
This person is not in any offices
Athos Therapeutics Inc
Athos Therapeutics is a late pre-clinical stage biotechnology company pioneering the development of artificial intelligence-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.